Home
Lynx1 Capital Management reported a 19.6% stake in Passage BIO PASG · 623,704 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 19.6%
- Last report
- 15% · filed 25/02/14
- Shares held
- 623,704 sh
- Class
- Common Stock, par value $0.0001 per share
- Stock
- Passage BIO PASG
- Holder
- Lynx1 Capital Management
- Event date
- 25/09/30
- Filed
- 25/11/14
19.6% stake · +4.6pp from the last report
- Stake
- 19.6%
- Last report
- 15%
- Since last report
- +4.6pp
Passage BIO trades, last 26 weeks
What else happened in Passage BIO around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Lynx1 Capital Management's other 5% stake reports
- Lynx1 Capital Management
5% stakeTScan Therapeutics
5% stakeTScan Therapeutics
TCRX
13.1% stake
20,519,148 sh
13.1% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeStoke Therapeutics
5% stakeStoke Therapeutics
STOK
6.5% stake
4,038,404 sh
6.5% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeC4 Therapeutics
5% stakeC4 Therapeutics
CCCC
9.99% stake
15,423,691 sh
9.99% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeiBio
5% stakeiBio
IBIO
5.4% stake
2,807,016 sh
5.4% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeGH Research
5% stakeGH Research
GHRS
19.3% stake
13,263,288 sh
19.3% stake
Filed 08/14
